reata pharmaceuticals inc stock

RETA stock opened at 3000 on Friday. Get the latest Reata Pharmaceuticals Inc RETA real-time quote historical performance charts and other financial information to help you make more informed trading and investment.


Buy Reata Pharmaceuticals Inc Stock View Reta Share Price On Etoro

View daily weekly or monthly format back to when Reata Pharmaceuticals Inc.

. Reata Pharmaceuticals Stock Performance. Reata Pharmaceuticals Inc. NASDAQRETA may have lost US207m in value but insiders who invested last year have seen gains of around US44k to date.

Not an offer or recommendation by Stocktwits. Find the latest Reata Pharmaceuticals Inc. Reatas development programs have created a robust pipeline of drug candidates for the treatment of serious life-threatening diseases.

RETA shares rallied 145 in the last trading session to close at 3454. The stock traded as high as 3999 and last traded at 3826. Reata Pharmaceuticals boosted investment sharply in the last year with cash burn ramping by 76.

Shares of RETA stock opened at 3000 on Friday. The move was backed by solid volume with far more shares changing. RETA stock opened at 3000 on Friday.

View Reata Pharmaceuticals Inc RETA investment stock information. RETA shares soared 206 in the last trading session to close at 3021. NASDAQRETA Get Rating shares rose 48 on Wednesday.

Class A Common Stock RETA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Find out more here. It is currently valued at 3000.

RETA stock quote history news and other vital information to help you with your stock trading and investing. Of course the truly verdant revenue growth of 104 in that time may well. For the readers interested in the stock health of Reata Pharmaceuticals Inc.

7 Wall Street analysts have issued twelve-month target prices for Reata Pharmaceuticals stock. RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that abstracts highlighting clinical. Reata Pharmaceuticals Inc.

This move can be attributable to notable volume with a higher number of. At Reata Pharmaceuticals Inc we promise to treat your data with respect and will not share your information with any third party. Discover historical prices for RETA stock on Yahoo Finance.

Insiders who bought Reata. The firm has a market cap of 109 billion a PE ratio of -358 and a beta of 107. Reata Pharmaceuticals has a 52-week low of 1847 and a 52-week high of 11480.

Reata Pharmaceuticals Inc. Reata Pharmaceuticals Inc. Get the latest Reata Pharmaceuticals Inc RETA detailed stock quotes stock data Real-Time ECN.

Reata Pharmaceuticals Stock Performance. Reata Pharmaceuticals Inc - Ordinary Shares - Class A 3000 266 815 Watch. Their RETA share price forecasts range from 2700 to 11200.

The firm has a market cap of 109 billion a PE ratio of -358 and a beta of 107. When the transactions were called off in the previous. The stock has a market cap of 109.

Get Reata Pharmaceuticals Inc RETANASDAQ real-time stock quotes news price and financial information from CNBC. You can unsubscribe to any of the investor alerts you are.


Reta Stock News Reta Reta Stock News Today Investor Alert Reata Pharmaceuticals Inc Reta Stock Youtube


Further Weakness As Reata Pharmaceuticals Nasdaq Reta Drops 6 9 This Week Taking One Year Losses To 80 Simply Wall St News


Reata Pharmaceuticals Inc Our Science


Reata Pharmaceuticals Inc 2022 Q2 Results Earnings Call Presentation Nasdaq Reta Seeking Alpha


The Law Offices Of Frank R Cruz Announces The Filing Of A Securities Class Action On Behalf Of Reata Pharmaceuticals Inc Reta Investors


Reta Stock News Today Reta Reta Stock Shareholders In Reata Pharmaceuticals Inc Class Action Youtube


2022 01 20 Ndaq Reta Press Release Reata Pharmaceuticals Inc


Reata Pharmaceuticals Inc Reta Stock Price Trades News Gurufocus


Why Reata Pharmaceuticals Stock Is Plunging Today The Motley Fool


Why Reata Pharma Shares Are Trading Lower After Q2 Earnings Update


Reata Pharmaceuticals Inc Bioworld


Why Reata Pharmaceuticals Could Perform Below Expectations Nasdaq Reta Seeking Alpha


Reata Pharmaceuticals Inc Class A Reta Option Trades


Reta Short Interest Reata Pharmaceuticals Inc Stock Short Squeeze Borrow Rates


Reata Pharmaceuticals Company Profile Stock Performance Earnings Pitchbook


Time To Worry Analysts Just Downgraded Their Reata Pharmaceuticals Inc Nasdaq Reta Outlook


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S


Reata Pharma Is Losing 33 Today Here S Why Best Stocks


Reata Pharmaceuticals Inc Announces Pricing Of Initial

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel